Integrated therapeutic strategies for anaplastic thyroid carcinoma

Roberto Buzzoni, Laura Catena, Diego Cortinovis, Giuseppina Dognini, Emilio Bajetta

Research output: Contribution to journalArticle


Anaplastic thyroid carcinoma (ATC) is a very rare neoplasm with an aggressive course. The prognosis has not changed in the last decades and the median survival does not exceed six months. Only few patients with incidental limited ATC will be cured. Different therapeutic options have been explored but the results are disappointing. At present, new drugs and new timing for proper treatment are under investigation. In this short review we have summarized these recent developments.

Original languageEnglish
Pages (from-to)544-546
Number of pages3
Issue number5
Publication statusPublished - Sep 2003



  • Anaplastic thyroid carcinoma
  • Chemotherapy
  • Integrated radiotherapeutic strategies

ASJC Scopus subject areas

  • Cancer Research

Cite this

Buzzoni, R., Catena, L., Cortinovis, D., Dognini, G., & Bajetta, E. (2003). Integrated therapeutic strategies for anaplastic thyroid carcinoma. Tumori, 89(5), 544-546.